Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(2R,3R,4R,5R)-tert-butyl 3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-5-(2-oxoethyl)pyrrolidine-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1567688-04-3

Post Buying Request

1567688-04-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1567688-04-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1567688-04-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,6,7,6,8 and 8 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1567688-04:
(9*1)+(8*5)+(7*6)+(6*7)+(5*6)+(4*8)+(3*8)+(2*0)+(1*4)=223
223 % 10 = 3
So 1567688-04-3 is a valid CAS Registry Number.

1567688-04-3Relevant articles and documents

Synthesis of novel polyhydroxylated pyrrolidine-triazole/-isoxazole hybrid molecules

Lin, Cheng-Kun,Cheng, Li-Wei,Li, Huang-Yi,Yun, Wen-Yi,Cheng, Wei-Chieh

, p. 2100 - 2107 (2015)

A straightforward synthesis of novel, 2-heterocyclyl polyhydroxylated pyrrolidines is described. Stereocontrolled additions of nucleophiles to cyclic nitrones generated the corresponding 2,3-trans adducts, allowing the synthesis of the corresponding pyrrolidines via key intermediates bearing an alkyne and a nitrile oxide. Three hybrid systems, including a pyrrolidine with two isoxazoles and one triazole, are efficiently prepared via 1,3-dipolar cycloaddition. Biological testing of the product alkaloids showed that subtle structural variations have drastic effects on their inhibitory activities against glucosidases. This journal is

GLYCOSIDASE INHIBITORS AND USES THEREOF

-

, (2014/03/25)

The invention provides compounds for inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1567688-04-3